Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials focused on the treatment and diagnosis of cancer. The company’s lead immunotherapy candidate, bavituximab, has been granted fast track designation by … Continue reading →

Rosetta Genomics, Ltd. (NASDAQ: ROSG) leverages an integrative research platform to develop and commercialize a full range of microRNA-based molecular diagnostics and address critical needs in cancer and other disease areas. Building on its proprietary platform technologies and a strong … Continue reading →

Ohr Pharmaceutical is an ophthalmology research and development company. Its lead product, Squalamine, is currently being studied as an eye drop formulation in several company sponsored and investigator sponsored phase II clinical trials for various back-of-the-eye diseases, including wet age-related … Continue reading →

Vycor Medical, Inc. (OTCQB: VYCO) is changing and improving lives every day by providing the medical community with innovative and superior surgical and therapeutic tools, including a growing portfolio of FDA-cleared medical solutions. The company currently operates two unique but … Continue reading →

Milestone Scientific, Inc. (NYSE: MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Since 1995, the company’s commitment to advancing the science of computer-controlled drug delivery technologies has helped it earn global distinction … Continue reading →

Torchlight Energy Resources, Inc. (NASDAQ: TRCH) is an oil and gas Exploration and Production company with a primary focus on acquisition and development of highly profitable domestic oil fields. Based in Plano, Texas, the company currently holds interests in Texas, … Continue reading →

Transition Therapeutics, Inc. (NASDAQ: TTHI) is a biopharmaceutical company developing novel therapeutics for disease indications with large markets. The company’s leading drug candidate, ELND005, is designed to treat the agitation and aggression associated with Alzheimer’s disease and Down syndrome. Additionally, … Continue reading →

InvenSense, Inc. (NYSE: INVN) is a leading provider of intelligent sensor system on chip (SoC) for motion and sound solutions in consumer electronic devices – including smartphones, tablets, wearables, gaming devices, optical image stabilization and remote controls for Smart TVs. … Continue reading →

In the U.S. alone each year, roughly 150k people develop some form of the seizure spectrum disorder known as epilepsy, which is the fourth most common neurological disorder known to man and which is characterized by not only unpredictable seizures, … Continue reading →